Financial services giant Bank of America (NYSE:BAC) will be announcing earnings results this Wednesday before market open.

Meghan Swiber, senior U.S. rates strategist at Bank of America's investment banking arm BofA Securities, joins WSJ’s Take On ...

Consensus predictions indicate revenues of approximately $26.77 billion for the quarter, reflecting a 5.5% increase year-over ...

Shares of Carvana Co. are down more than 2% in Wednesday morning trading after Bank of America analyst Nat Schindler downgraded the stock to neutral from buy, warning of the company's cash situation.

Discover Bank of America's robust stress test results, Q1 progress, and growth potential. Read my analysis of BAC stock.

On January 6, TipRanks reported that Koji Ikeda from Bank of America Securities reaffirmed the Buy rating on Dynatrace (NYSE:DT) with a $70.00 price target, driven by the company's strong position ...

Despite President Trump’s trade war, BofA strategists including Savita Subramanian and Jill Carey Hall predict that the S&P ...

Bank of America shares have seen quite a pullback over the past week. Read more to see my recommendation on BAC stock.

Bank of America Corp DE’s holdings in REGENXBIO were worth $2,174,000 at the end of the most recent quarter. Other large investors also recently modified their holdings of the company.

Bank of America Corp DE’s holdings in TTM Technologies were worth $7,352,000 at the end of the most recent quarter. Other hedge funds also recently bought and sold shares of the company.

Bank of America (BAC) closed the most recent trading day at $42.21, moving +1.34% from the previous trading session.